Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Jul 7, 2026
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $53 as of July 9, 2026.
Market Cap
53.00
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 53.00, a decrease of -100.00%. That is a compound annual growth rate of -83.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 53.00 | -99.93% |
| Dec 31, 2025 | 79.98K | 1,400.02% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infinity Pharmaceuticals | 91.00 |
| American Oriental Bioengineering | 88.00 |
| RenovaCare | 87.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |